Respiratory multiple infections by bacteria, virus, fungus and parasite in a COPD patient, A case report

Main Article Content

Eissa Soleymani
Shadi Shayesteh Azar
Keihan Shabankhani
Seyed Reza Mirbadie
Roya Najafi-Vosough
Mahdi Fakhar


SARS-CoV-2 is the causative agent of COVID-19, an infection that can manifest with mild to severe respiratory symptoms. A 70-year-old man with COVID-19 and COPD presented to a hospital complaining of breathing difficulties. A sample was taken leading to the finding of the Acanthamoeba parasite. Stenotrophomonas maltophilia, a bacterium known for its resistance to most antibiotics and its significance as a nosocomial pathogen, was identified. Furthermore, for the first time, Gloeotinia fungus was discovered as an endosymbiont of Acanthamoeba. The patient underwent a successful treatment and was discharged from hospital. Immunocompromised persons should be concerned about the increasing incidence of nosocomial infections. The presence of Acanthamoeba should not be overlooked in respiratory disorders, as it has the potential to carry numerous pathogenic microorganisms as endosymbionts.

Article Details

How to Cite
Soleymani, E., Shayesteh Azar, S., Shabankhani, K., Mirbadie, S. R., Najafi-Vosough, R., & Fakhar, M. (2024). Respiratory multiple infections by bacteria, virus, fungus and parasite in a COPD patient, A case report. Afghanistan Journal of Infectious Diseases, 2(2), 105–108.
Case reports


O'Toole RF. The interface between COVID-19 and bacterial healthcare-associated infections. Clin Microbiol Infect. 2021;27(12):1772-6.

Taheri A, Davoodi L, Soleymani E, Ahmadi N. New-onset myasthenia gravis after novel coronavirus 2019 infection. Respirol Case Rep. 2022;10(6):e0978.

Wu HY, Chang PH, Chen KY, Lin IF, Hsih WH, Tsai WL, et al. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment. J Microbiol Immunol Infect. 2022;55(6 Pt 1):985-92.

Elabbadi A, Turpin M, Gerotziafas GT, Teulier M, Voiriot G, Fartoukh M. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia. Infection. 2021;49(3):559-62.

Siddiqui R, Niyyati M, Abouleish MY, Khamis M, Ibrahim T, Khan NA. COVID-19: Acanthamoeba Creeps into the Brain. Iran J Parasitol. 2023;18(2):272-4.

Li K, Yu K, Huang Z, Liu X, Mei L, Ren X, et al. Stenotrophomonas maltophilia complex: insights into evolutionary relationships, global distribution and pathogenicity. Frontiers in Cellular and Infection Microbiology. 2024;13:1325379.

Niyyati M, Rezaeian M. Current Status of Acanthamoeba in Iran: A Narrative Review Article. Iran J Parasitol. 2015;10(2):157-63.

Soleymani E, Fakhar M, Davoodi L, Motavallihaghi S, Sharifpour A, Maghsood AH. Isolation, characterization, and pathogenicity assay of Acanthamoeba and its endosymbionts in respiratory disorders and COVID-19 hospitalized patients, northern Iran. Exp Parasitol. 2024;262:108774.

Rayamajhee B, Willcox MDP, Henriquez FL, Petsoglou C, Subedi D, Carnt N. Acanthamoeba, an environmental phagocyte enhancing survival and transmission of human pathogens. Trends in Parasitology. 2022;38(11):975-90.

Henriquez FL. Khan NA: Acanthamoeba: Biology and Pathogenesis. Parasites & Vectors. 2009;2(1):16.

Hajialilo E, Rezaeian M, Niyyati M, Pourmand MR, Mohebali M, Norouzi M, et al. Molecular characterization of bacterial, viral and fungal endosymbionts of Acanthamoeba isolates in keratitis patients of Iran. Exp Parasitol. 2019;200:48-54.

Mirabedini Z, Ahmed Khan N, Niyyati M, Javanmard E, Hamedanipour M, Arab-Mazar Z. Can Free Living Acanthamoeba Act as a Trojan Horse for SARS-Cov-2 on Viral Survival and Transmission in the Environment? A Narrative Review. Iran J Parasitol. 2022;17(2):138-44.

Viviano a, Benvenuti c, Strangi a, Iovinella i, Mazza g, Paolo g, et al. Preliminary assessment of entomopathogenic fungi and nematodes in hot springs in central Italy with the first record of Pristionchus uniformis for the country. Biogeographia–The Journal of Integrative Biogeography. 2022;37:a017.

Fritsche TR, Sobek D, Gautom RK. Enhancement of in vitro cytopathogenicity by Acanthamoeba spp. following acquisition of bacterial endosymbionts. FEMS Microbiol Lett. 1998;166(2):231-6.